1. Dedrick RL, Myers CE, Bungay PM, DeVita VT Jr (1978) Pharmacokinetic rationale for peritoneal administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1–11
2. Jones RB, Collins JM, Myers CE et al (1981) High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Cancer Res 41:55–59
3. Ozols R, Locker GY, Doroshow JH, Grotzinger KR, Myers CE, Young RC (1979) Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 39: 3209–3214
4. Ozols RF, Young RC, Speyer JL, Sugarbaker PH, Greene R, Jenkins J, Myers CE (1982) Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 42:4265–4269
5. Speyer JL, Collins JM, Dedrick RL et al (1980) Phase I and pharmacological studies of 5-fluoruracil administered intraperitoneally. Cancer Res 40:567–572